United Therapeutics Corporation reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was USD 714.9 million compared to USD 596.5 million a year ago. Net income was USD 278.1 million compared to USD 259.2 million a year ago. Basic earnings per share from continuing operations was USD 6.26 compared to USD 5.53 a year ago. Diluted earnings per share from continuing operations was USD 5.85 compared to USD 5.24 a year ago.
For the six months, sales was USD 1,392.6 million compared to USD 1,103.4 million a year ago. Net income was USD 584.7 million compared to USD 500.1 million a year ago. Basic earnings per share from continuing operations was USD 12.79 compared to USD 10.73 a year ago. Diluted earnings per share from continuing operations was USD 12.03 compared to USD 10.08 a year ago.